Table 1 Baseline characteristics of the study population
|
Recurrence Group (n = 30) |
Successful Group (n = 107) | p value | |
|---|---|---|---|
| Age, years | 59.4 ± 10.5 | 61.3 ± 10.7 | 0.22 |
| Females, n (%) | 9 (30) | 31 (29) | 0.91 |
| Body mass index, kg/cm2 | 24.2 ± 3.3 | 23.9 ± 3.2 | 0.43 |
| Heart rate, beat per minute | 72 ± 15 | 73 ± 15 | 0.77 |
| Systolic blood pressure, mmHg | 121 ± 17 | 121 ± 15 | 0.83 |
| Diastolic blood pressure, mmHg | 75 ± 14 | 73 ± 11 | 0.45 |
| eGFR, ml/min/1.73 m2 | 73.8 ± 16.2 | 72.8 ± 17.5 | 0.82 |
| Previous ablation, n (%) | 9 (30) | 19 (18) | 0.14 |
| Hypertension, n (%) | 14 (47) | 49 (46) | 0.93 |
| Diabetes mellitus, n (%) | 5 (17) | 17 (16) | >0.99 |
| Coronary artery disease, n (%) | 2 (7) | 6 (6) | >0.99 |
| Smoking, n (%) | 5 (17) | 17 (16) | >0.99 |
| Anti-arrhythmic drugs, n (%) | 16 (53) | 49 (46) | 0.47 |
| Congestive heart failure, n (%) | 3 (10) | 9 (8) | 0.73 |
| CHA2DS2-VASc score | 1.4 ± 1.3 | 1.4 ± 1.2 | 0.83 |